Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zu Kapitel 1.10
Barthels M, von Depka M (2003) Das Gerinnungskompendium. Thieme, Stuttgart
Bauersachs RM (2001) Produktprofil von Pentasaccharid (Fondaparinux-Natrium). Hämostaseologie 21:146–150
Bode C, Kohler B, Moser M, Zimmermann R, Strasser RH, Kubler W (1997) Antithrombotische Prävention und Therapie bei koronarer Herzerkrankung. Internist 38:658–666
Caprie Steering Commitee (1996) A randomised blinded, trial of clopidogrel versus a aspiring in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339
Cohen M, Arjomand H, Pollack CV Jr (2004) The evolution of thrombolytic therapy and adjunctive antithrombotic regimes in acute ST-segment elevation myocardial infarction. Am J Emerg Med 22(1):14–23
Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds) Hemostasis and thrombosis. Lippincott Williams & Wilkin, Philadelphia, pp 103–121
DIN 58911 Teil 1. Hämostaseologie, Kalibrierung von Meßverfahren. DIN Taschenbuch 261 1996, „Hämostaseologie“ Beuth, Berlin
Gawaz M (2001) Blood platelets. Thieme, Stuttgart
Haas S, Haas P (1996) Niedermolekulare Heparine. Die Anwendung in Klinik und Praxis. Zett-Verlag, Steinen
Hiller E, Riess H (Hrsg) (1998) Hämorrhagische Diathese und Thrombose. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Himmelreich G, Riess H (1991) Klinische Bedeutung des Fibrinolysesystems. Dtsch med Wschr 116:426–430
Hirsh J (1995) Oral anticoagulants: mechanisms of action, clinical effectiveness, and optimal therapeutic range. Chest 108(4):23–246
Mehta P (2002) Aspirin in the prophylaxis of coronary artery disease. Curr Opin Cardiol 17(5):552–558
Nordt TK, Bode C (2003) Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart 89(11):1358–1362
Ostermann H (1997) Indikationen und Probleme langfristiger medikamentöser Gerinnungshemmung. Internist 38:672–679
Riess H, Riewald M (1994) The clinical impact of platelet function testing. Thromb Res 74:69–78
Sack U, Rothe G, Barlage S, Gruber R, Kabelitz D, Kleine TO et al (2000) Durchflusszytometrie in der klinischen Diagnostik. J Lab Med 24:277–297
Sadosty AT, Boie ET, Stead LG (2003) Pulmonary embolism. Emerg Med Clin North Am 21(2):363–384
Schmidt BMW, Wehling M (1997) Der Einsatz von Thrombozytenaggregationshemmern in der Kardiologie. Internist 38:1242–1246
Schmitz G, Rothe G, Ruf A et al (1998) European working group on clinical cell analysis: consensus protocoll for the flow cytometric characterisation of platelet function. Thromb Haemost 79:885–896
Smythe MA, Koerber JM, Westley SJ et al (2000) Use of the activated partial thromboplastin time for heparin monitoring. Am J Clin Pathol 115:148–155
Vermylen J, Verhaege R (1997) New platelet aggregation inhibitors. Hämostaseologie 17:43–48
Warkentin TE, Greinacher A (eds) (2000) Heparin induced thrombocytopenia. Marcel Dekker, New York, pp 261–290
Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286–1292
Weber AA, Schrör K (1997) Pharmakologie von Ticlopidin und Clopidogrel im Vergleich zu Acetylsalicylsäure. Internist 38:1115–1120
Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interactions of warfarin with drugs and food. Ann Int Med 121:676–683
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Riess, H. (2006). Antikoagulation und Gerinnungsanalyse, Interpretation — Schnellorientierung. In: Zerkowski, H.R., Baumann, G. (eds) HerzAkutMedizin. Steinkopff. https://doi.org/10.1007/3-7985-1630-8_11
Download citation
DOI: https://doi.org/10.1007/3-7985-1630-8_11
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1505-5
Online ISBN: 978-3-7985-1630-4
eBook Packages: Medicine (German Language)